当前位置:首页 - 行情中心 - 九洲药业(603456) - 财务分析 - 现金流量表

九洲药业

(603456)

  

流通市值:117.50亿  总市值:117.50亿
流通股本:8.89亿   总股本:8.89亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,167,024,840.85,379,858,169.924,275,489,879.132,801,518,807.61
  收到的税费返还89,282,796.6244,873,943.28208,725,713124,908,656.34
  收到其他与经营活动有关的现金94,724,379.59224,820,958.39241,355,825.98192,680,720.66
  经营活动现金流入小计1,351,032,016.995,849,553,071.594,725,571,418.113,119,108,184.61
  购买商品、接受劳务支付的现金707,719,546.672,451,667,702.352,111,258,852.371,365,765,212.56
  支付给职工以及为职工支付的现金313,670,629.19916,088,149.72717,342,209.16495,084,704.81
  支付的各项税费87,891,506.22362,708,151.14303,744,471.69219,489,280
  支付其他与经营活动有关的现金105,803,345.43294,842,846.45251,220,845.4193,620,842.63
  经营活动现金流出小计1,215,085,027.514,025,306,849.663,383,566,378.622,273,960,040
  经营活动产生的现金流量净额135,946,989.481,824,246,221.931,342,005,039.49845,148,144.61
二、投资活动产生的现金流量:
  收回投资收到的现金340,492,194.9-2,769,230.772,769,230.77
  取得投资收益收到的现金4,085,056.525,024,350.34--
  处置固定资产、无形资产和其他长期资产收回的现金净额407,096.615,336,226.743,053,684.761,980,400.04
  处置子公司及其他营业单位收到的现金净额8,316.54---
  投资活动现金流入小计344,992,664.5710,360,577.085,822,915.534,749,630.81
  购建固定资产、无形资产和其他长期资产支付的现金151,629,821.1660,089,439.9434,459,528.27287,285,184.8
  投资支付的现金335,769,405.521,382,371,138.76100,000,000100,000,000
  投资活动现金流出小计487,399,226.622,042,460,578.66534,459,528.27387,285,184.8
  投资活动产生的现金流量净额-142,406,562.05-2,032,100,001.58-528,636,612.74-382,535,553.99
三、筹资活动产生的现金流量:
  取得借款收到的现金90,000,000470,000,000470,000,000300,000,000
  筹资活动现金流入小计90,000,000470,000,000470,000,000300,000,000
  偿还债务支付的现金50,000,000815,812,534.16745,848,313.91295,848,313.91
  分配股利、利润或偿付利息支付的现金1,230,030455,306,266.56453,456,095.42271,697,387.99
  其中:子公司支付给少数股东的股利、利润-4,900,000--
  支付其他与筹资活动有关的现金-111,593,897.18106,264,596106,263,192.89
  筹资活动现金流出小计51,230,0301,382,712,697.91,305,569,005.33673,808,894.79
  筹资活动产生的现金流量净额38,769,970-912,712,697.9-835,569,005.33-373,808,894.79
四、汇率变动对现金及现金等价物的影响-18,500,052.73-17,015,588.67-4,113,3554,568,061.65
  现金及现金等价物净增加额平衡项目000.010.01
五、现金及现金等价物净增加额13,810,344.7-1,137,582,066.22-26,313,933.5793,371,757.49
  加:期初现金及现金等价物余额1,456,099,928.742,593,681,994.962,593,681,994.962,593,681,994.96
  期末现金及现金等价物余额1,469,910,273.441,456,099,928.742,567,368,061.392,687,053,752.45
补充资料:
  净利润-728,543,117.48-526,613,903.71
  资产减值准备-337,761,490.03-40,716,046.36
  固定资产和投资性房地产折旧-370,373,372.02-182,893,221.29
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-370,373,372.02-182,893,221.29
  无形资产摊销-43,988,387.1-22,658,558.35
  长期待摊费用摊销-3,445,908.52-2,125,664.17
  处置固定资产、无形资产和其他长期资产的损失-5,159,651.38-1,859,197.68
  固定资产报废损失-1,222,476.82-426,427.23
  财务费用-23,059,530.07-6,581,031.08
  投资损失--3,555,802.23-1,839,698.01
  递延所得税--11,557,358.38-2,441,164.15
  其中:递延所得税资产减少-1,615,712.51-327,376.42
    递延所得税负债增加--13,173,070.89-2,113,787.73
  存货的减少-349,330,400.45-368,080,101.1
  经营性应收项目的减少-162,649,253.74--3,074,235.65
  经营性应付项目的增加--181,320,332.7--311,860,739.64
  其他-2,198,228.77-7,198,030.12
  现金的期末余额-1,456,099,928.74-2,687,053,752.45
  减:现金的期初余额-2,593,681,994.96-2,593,681,994.96
  现金及现金等价物的净增加额--1,137,582,066.22-93,371,757.49
公告日期2026-04-242026-04-242025-10-162025-08-06
审计意见(境内)标准无保留意见
TOP↑